Form 4 for BSX Boston Scientific
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-10 · accession 0001225208-21-011391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-11 | 2021-08-10 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $13.08 | +20.0K | 86.1K | +30% | +$261.6K |
| D | 2021-08-11 | 2021-08-10 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 20,000 | $13.08 | 86,128.99 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-10 | M | D | 20,000 | $0.00 | 0 | D | $13.08 · — to 2024-02-24 | 20,000 Common Stock | (F1) Grant to the reporting person of an option to purchase 20,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |